Huaren Pharmaceutical Co (SZSE:300110) E10: ¥-0.09 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:300110 Huaren Pharmaceutical Co Ltd SZSE:300110
55 GF Score
Price ¥2.90
GF Value ¥3.13
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Huaren Pharmaceutical Co E10?

Huaren Pharmaceutical Co SZSE:300110 +0.35% 55 E10 is ¥-0.09 as of Mar. 2026. GuruFocus rates SZSE:300110 with a GF Score™ of 55/100 and a GF Value™ of ¥3.13 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Huaren Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.014. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥-0.09 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Huaren Pharmaceutical Co was 5.30% per year. The lowest was 0.00% per year. And the median was 0.00% per year.

As of today (2026-08-26), Huaren Pharmaceutical Co's current stock price is ¥2.90. Huaren Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was ¥-0.09. Huaren Pharmaceutical Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Huaren Pharmaceutical Co was 105.14. The lowest was 35.50. And the median was 60.43.


Huaren Pharmaceutical Co  (SZSE:300110) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Huaren Pharmaceutical Co was 105.14. The lowest was 35.50. And the median was 60.43.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Huaren Pharmaceutical Co E10 Related Terms


Huaren Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Huaren Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Huaren Pharmaceutical Co E10 Chart

Huaren Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.07 0.07 -0.05 -0.09

Huaren Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.05 -0.05 -0.09 -0.09

SZSE:300110 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Huaren Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huaren Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huaren Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Huaren Pharmaceutical Co's Shiller PE Ratio falls into.


SZSE:300110
55GF Score
Huaren Pharmaceutical Co Ltd SZSE:300110
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Huaren Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Huaren Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.014/116.3033*116.3033
=0.014

Current CPI (Mar. 2026) = 116.3033.

Huaren Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.001 101.400 0.001
201609 0.010 102.400 0.011
201612 0.007 102.600 0.008
201703 0.005 103.200 0.006
201706 0.004 103.100 0.005
201709 0.012 104.100 0.013
201712 0.019 104.500 0.021
201803 0.002 105.300 0.002
201806 0.013 104.900 0.014
201809 0.010 106.600 0.011
201812 0.009 106.500 0.010
201903 0.004 107.700 0.004
201906 0.007 107.700 0.008
201909 0.011 109.800 0.012
201912 0.014 111.200 0.015
202003 0.005 112.300 0.005
202006 0.025 110.400 0.026
202009 0.016 111.700 0.017
202012 0.034 111.500 0.035
202103 0.021 112.662 0.022
202106 0.041 111.769 0.043
202109 0.037 112.215 0.038
202112 0.011 113.108 0.011
202203 0.021 114.335 0.021
202206 0.042 114.558 0.043
202209 0.042 115.339 0.042
202212 0.049 115.116 0.050
202303 0.035 115.116 0.035
202306 0.035 114.558 0.036
202309 0.046 115.339 0.046
202312 0.043 114.781 0.044
202403 0.043 115.227 0.043
202406 0.019 114.781 0.019
202409 0.019 115.785 0.019
202412 -1.238 114.893 -1.253
202503 0.014 115.116 0.014
202506 0.018 114.907 0.018
202509 0.015 115.471 0.015
202512 -0.438 115.832 -0.440
202603 0.014 116.303 0.014

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥-0.09 mean?
Huaren Pharmaceutical Co (SZSE:300110) has a E10 of ¥-0.09 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Huaren Pharmaceutical Co and its competitors.
Is Huaren Pharmaceutical Co's E10 too high?
Huaren Pharmaceutical Co's current E10 is ¥-0.09. Overall, Huaren Pharmaceutical Co has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Huaren Pharmaceutical Co's E10 compare to ZTS?
Huaren Pharmaceutical Co's E10 of ¥-0.09 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Huaren Pharmaceutical Co and its competitors. Huaren Pharmaceutical Co's current E10 is ¥-0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huaren Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Huaren Pharmaceutical Co (SZSE:300110) is currently considered Fairly Valued. The stock's GF Value™ is ¥3.13, compared to a current price of ¥2.90 — trading 7.3% below its estimated fair value. The current E10 is ¥-0.09. Huaren Pharmaceutical Co's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Huaren Pharmaceutical Co (SZSE:300110), the current E10 is ¥-0.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Huaren Pharmaceutical Co (SZSE:300110) Overvalued in 2026?

Based on GuruFocus' analysis, Huaren Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥2.90 is trading 7.3% below its estimated GF Value™ of ¥3.13. GuruFocus considers Huaren Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SZSE:300110:

  • E10: ¥-0.09
  • GF Value™: ¥3.13 vs. price of ¥2.90 (7.3% below fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the SZSE:300110 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Huaren Pharmaceutical Co Business Description

Address No. 187 Zhuzhou Road, Qingdao, Shandong, CHN, 266100
Huaren Pharmaceutical Co Ltd is a China-based company engaged in the manufacture, and sale of non-polyvinyl chloride and Non-PVC large capacity preparations. Its categories of products include conventional infusion, therapy infusion, and nutrition infusion. The company distributes its products in domestic market, with Northeast China as its main market.
55GF Score

Get the complete analysis for SZSE:300110

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.90
Price
¥3.13
GF Value